O
BLRX
OrbiMed’s BioLineRX BLRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-69,240
| Closed | -$114K | – | 150 |
|
2020
Q3 | $114K | Hold |
69,240
| – | – | ﹤0.01% | 140 |
|
2020
Q2 | $118K | Hold |
69,240
| – | – | ﹤0.01% | 131 |
|
2020
Q1 | $92K | Hold |
69,240
| – | – | ﹤0.01% | 138 |
|
2019
Q4 | $156K | Hold |
69,240
| – | – | ﹤0.01% | 131 |
|
2019
Q3 | $183K | Sell |
69,240
-969,360
| -93% | -$2.56M | ﹤0.01% | 107 |
|
2019
Q2 | $379K | Hold |
1,038,600
| – | – | 0.01% | 118 |
|
2019
Q1 | $447K | Hold |
1,038,600
| – | – | 0.01% | 115 |
|
2018
Q4 | $454K | Hold |
1,038,600
| – | – | 0.01% | 121 |
|
2018
Q3 | $1.11M | Hold |
1,038,600
| – | – | 0.01% | 141 |
|
2018
Q2 | $924K | Hold |
1,038,600
| – | – | 0.01% | 134 |
|
2018
Q1 | $904K | Hold |
1,038,600
| – | – | 0.01% | 123 |
|
2017
Q4 | $1.13M | Hold |
1,038,600
| – | – | 0.01% | 123 |
|
2017
Q3 | $1.16M | Hold |
1,038,600
| – | – | 0.01% | 128 |
|
2017
Q2 | $878K | Hold |
1,038,600
| – | – | 0.01% | 127 |
|
2017
Q1 | $998K | Hold |
1,038,600
| – | – | 0.01% | 125 |
|
2016
Q4 | $956K | Hold |
1,038,600
| – | – | 0.01% | 120 |
|
2016
Q3 | $1.19M | Hold |
1,038,600
| – | – | 0.01% | 123 |
|
2016
Q2 | $831K | Hold |
1,038,600
| – | – | 0.01% | 124 |
|
2016
Q1 | $1.06M | Hold |
1,038,600
| – | – | 0.01% | 134 |
|
2015
Q4 | $1.35M | Hold |
1,038,600
| – | – | 0.01% | 120 |
|
2015
Q3 | $1.59M | Sell |
1,038,600
-96,400
| -8% | -$147K | 0.02% | 123 |
|
2015
Q2 | $3.02M | Hold |
1,135,000
| – | – | 0.03% | 116 |
|
2015
Q1 | $2.4M | Hold |
1,135,000
| – | – | 0.02% | 116 |
|
2014
Q4 | $1.84M | Hold |
1,135,000
| – | – | 0.02% | 114 |
|
2014
Q3 | $1.75M | Hold |
1,135,000
| – | – | 0.02% | 113 |
|
2014
Q2 | $2.36M | Hold |
1,135,000
| – | – | 0.03% | 111 |
|
2014
Q1 | $2.53M | Hold |
1,135,000
| – | – | 0.03% | 113 |
|
2013
Q4 | $3.19M | Sell |
1,135,000
-200,000
| -15% | -$562K | 0.05% | 100 |
|
2013
Q3 | $2.92M | Sell |
1,335,000
-254,500
| -16% | -$557K | 0.05% | 98 |
|
2013
Q2 | $2.58M | Buy |
+1,589,500
| New | +$2.58M | 0.05% | 104 |
|